Lin J, Xue B, Li J, Zhu R, Pan J, Chen Z
Front Neurol. 2022; 13:891064.
PMID: 35599732
PMC: 9120916.
DOI: 10.3389/fneur.2022.891064.
Logoida M, Kristian P, Schreiberova A, Lenartova P, Bednarova V, Hatalova E
Pathogens. 2022; 11(1).
PMID: 35055968
PMC: 8780131.
DOI: 10.3390/pathogens11010020.
Lee C, Shah M, Hoyos D, Solovyov A, Douglas M, Taur Y
Cancer Discov. 2021; 12(1):62-73.
PMID: 34753749
PMC: 8758535.
DOI: 10.1158/2159-8290.CD-21-1033.
Li Y, Yin S, Issa R, Tong X, Wang G, Xia J
J Clin Transl Hepatol. 2021; 9(4):592-597.
PMID: 34447690
PMC: 8369012.
DOI: 10.14218/JCTH.2021.00051.
Silva R, do Nascimento R, Oliveira-Neto J, Silva F, Piauiense J, Gomes C
Viruses. 2021; 13(7).
PMID: 34372586
PMC: 8310228.
DOI: 10.3390/v13071380.
Detection of S-HBsAg Mutations in Patients with Hematologic Malignancies.
Konopleva M, Belenikin M, Shanko A, Bazhenov A, Kiryanov S, Tupoleva T
Diagnostics (Basel). 2021; 11(6).
PMID: 34072185
PMC: 8228241.
DOI: 10.3390/diagnostics11060969.
[Consensus of Chinese experts on prevention and standardized treatment of drug-induced liver injury in patients with blood diseases (2021)].
Zhonghua Xue Ye Xue Za Zhi. 2021; 42(3):185-192.
PMID: 33910302
PMC: 8081943.
DOI: 10.3760/cma.j.issn.0253-2727.2021.03.002.
Safety and efficacy of CAR-T cell targeting BCMA in patients with multiple myeloma coinfected with chronic hepatitis B virus.
Han L, Zhou J, Zhou K, Zhu X, Zhao L, Fang B
J Immunother Cancer. 2020; 8(2).
PMID: 32792360
PMC: 7430488.
DOI: 10.1136/jitc-2020-000927.
Immune-Escape Hepatitis B Virus Mutations Associated with Viral Reactivation upon Immunosuppression.
Lazarevic I, Banko A, Miljanovic D, Cupic M
Viruses. 2019; 11(9).
PMID: 31450544
PMC: 6784188.
DOI: 10.3390/v11090778.
Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention.
Sagnelli C, Pisaturo M, Calo F, Martini S, Sagnelli E, Coppola N
World J Gastroenterol. 2019; 25(26):3299-3312.
PMID: 31341357
PMC: 6639550.
DOI: 10.3748/wjg.v25.i26.3299.
Roles of Hepatitis B Virus Mutations in the Viral Reactivation after Immunosuppression Therapies.
Inoue J, Nakamura T, Masamune A
Viruses. 2019; 11(5).
PMID: 31109119
PMC: 6563158.
DOI: 10.3390/v11050457.
Reactivation of hepatitis B virus infection in patients with hematologic disorders.
Wang B, Mufti G, Agarwal K
Haematologica. 2019; 104(3):435-443.
PMID: 30733266
PMC: 6395346.
DOI: 10.3324/haematol.2018.210252.
Hepatitis B virus infection: Defective surface antigen expression and pathogenesis.
Wu C, Chen Y, Cao L, Chen X, Lu M
World J Gastroenterol. 2018; 24(31):3488-3499.
PMID: 30131655
PMC: 6102499.
DOI: 10.3748/wjg.v24.i31.3488.
Do we need better hepatitis B vaccines?.
Gerlich W
Indian J Med Res. 2017; 145(4):414-419.
PMID: 28862172
PMC: 5663154.
DOI: 10.4103/ijmr.IJMR_1852_16.
Using health-system-wide data to understand hepatitis B virus prophylaxis and reactivation outcomes in patients receiving rituximab.
Schmajuk G, Tonner C, Trupin L, Li J, Sarkar U, Ludwig D
Medicine (Baltimore). 2017; 96(13):e6528.
PMID: 28353614
PMC: 5380298.
DOI: 10.1097/MD.0000000000006528.
Prevalence of hepatitis B and C infections in rheumatoid arthritis and ankylosing spondylitis: A multicenter countrywide study.
Yilmaz N, Karadag O, Kimyon G, Yazici A, Yilmaz S, Kalyoncu U
Eur J Rheumatol. 2016; 1(2):51-54.
PMID: 27708874
PMC: 5042277.
DOI: 10.5152/eurjrheumatol.2014.018.
Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis.
Shah S, Geetha D
Immunotargets Ther. 2016; 4:173-83.
PMID: 27471722
PMC: 4918256.
DOI: 10.2147/ITT.S55516.
[Expert panel consensus statement on prevention and standardized treatment of drug-induced liver injury in patients with blood diseases (2016)].
Zhonghua Xue Ye Xue Za Zhi. 2016; 37(6):441-52.
PMID: 27431065
PMC: 7348330.
DOI: 10.3760/cma.j.issn.0253-2727.2016.06.001.
Genetic variation of occult hepatitis B virus infection.
Zhu H, Li X, Li J, Zhang Z
World J Gastroenterol. 2016; 22(13):3531-46.
PMID: 27053845
PMC: 4814639.
DOI: 10.3748/wjg.v22.i13.3531.
The effect of anticancer therapy on anti-hepatitis B antibody titres in patients with haematological malignancies and solid tumours.
Yilmaz B, Erdem D, Teker F, Goren I, Yildirim B, Kut E
J Int Med Res. 2016; 44(3):627-38.
PMID: 27048386
PMC: 5536710.
DOI: 10.1177/0300060516638992.
